Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
HZNP | Horizon Therapeutics Public Ltd Co | Watkins Thomas | Director | Oct 06, 2023 | Option Exercise | $116.50 | 110,447 | 12,867,076 | 0 | Oct 06, 2023, 06:24 PM | |
HZNP | Horizon Therapeutics Public Ltd Co | Watkins Thomas | Director | Oct 06, 2023 | Option Exercise | $116.50 | 10,000 | 1,165,000 | 0 | Oct 06, 2023, 06:24 PM | |
HZNP | Horizon Therapeutics Public Ltd Co | Watkins Thomas | Director | Oct 06, 2023 | Option Exercise | $116.50 | 55,953 | 6,518,525 | 0 | Oct 06, 2023, 06:24 PM | |
HZNP | Horizon Therapeutics Public Ltd Co | Watkins Thomas | Director | Sep 29, 2023 | Option Exercise | $13.61 | 81,323 | 1,106,550 | 110,447 | Oct 02, 2023, 07:32 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | Jun 02, 2022 | Option Exercise | $4.15 | 15,000 | 62,250 | 69,505 | Jun 03, 2022, 04:31 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | Jun 02, 2022 | Sale | $9.90 | 6,441 | 63,779 | 63,064 | Jun 03, 2022, 04:31 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | Feb 16, 2021 | Option Exercise | $7.11 | 15,000 | 106,650 | 55,323 | Feb 18, 2021, 08:43 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | Feb 16, 2021 | Sale | $18.54 | 5,818 | 107,856 | 49,505 | Feb 18, 2021, 08:43 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | May 29, 2020 | Sale | $11.50 | 9,677 | 111,286 | 35,323 | Jun 02, 2020, 04:13 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | May 29, 2020 | Option Exercise | $7.38 | 15,000 | 110,700 | 45,000 | Jun 02, 2020, 04:13 PM | |
HZNP | Horizon Therapeutics Public Ltd Co | Watkins Thomas | Director | May 03, 2019 | Option Exercise | $26.54 | 4,132 | 109,663 | 44,453 | May 06, 2019, 05:51 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | May 03, 2018 | Option Exercise | $4.98 | 15,000 | 74,700 | 20,000 | May 04, 2018, 04:06 PM | |
HZNP | Horizon Pharma plc | Watkins Thomas | Director | Aug 19, 2015 | Buy | $31.32 | 10,000 | 313,240 | 10,000 | Aug 21, 2015, 06:32 PM | |
HZNP | Horizon Pharma plc | Watkins Thomas | Director | Aug 14, 2014 | Buy | $9.76 | 6,000 | 58,560 | 6,000 | Jan 26, 2015, 09:00 AM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | Mar 14, 2014 | Option Exercise | $9.40 | 35,000 | 329,000 | 35,000 | Mar 17, 2014, 04:49 PM | |
VNDA | Vanda Pharmaceuticals Inc. | Watkins Thomas | Director | Mar 14, 2014 | Sale | $17.66 | 35,000 | 618,170 | 0 | Mar 17, 2014, 04:49 PM | |
HGSI | HUMAN GENOME SCIENCES INC | Watkins Thomas | Chief Executive Officer | Jun 30, 2011 | Buy | $20.62 | 1,030 | 21,239 | 169,105 | Aug 17, 2012, 10:29 AM | |
HGSI | HUMAN GENOME SCIENCES INC | Watkins Thomas | Chief Executive Officer | Jun 29, 2012 | Buy | $6.32 | 3,364 | 21,260 | 177,469 | Aug 17, 2012, 10:29 AM | |
HGSI | HUMAN GENOME SCIENCES INC | Watkins Thomas | Chief Executive Officer | Jul 30, 2012 | Option Exercise | $14.25 | 10,469 | 149,183 | 0 | Aug 17, 2012, 10:29 AM | |
HGSI | HUMAN GENOME SCIENCES INC | Watkins Thomas | Chief Executive Officer | Jul 25, 2012 | Option Exercise | $14.25 | 166,075 | 2,366,569 | 0 | Aug 01, 2012, 03:22 PM | |
HGSI | HUMAN GENOME SCIENCES INC | Watkins Thomas | Chief Executive Officer | Jan 05, 2011 | Buy | $24.16 | 60,000 | 1,449,600 | 66,000 | Jan 07, 2011, 11:50 AM |